Early Versus Conventional Cessation of Hydrocortisone in Septic Shock

Clinical trial NCT05818826 · UNKNOWN

Trial details

NCT number: NCT05818826
Sponsor: Mahidol University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Septic Shock Adverse Event Hydrocortisone Hyperglycemia Hypernatremia Muscle Weakness Superimposed Infection

Start date: 2023-07-05
Primary completion: 2025-04-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.